Lilac – CE
In 2018, Bhabhatron II was installed in Uganda and Madagascar, ensuring timely treatment of cancer in these unreached areas. With Lilac getting CE marked in 2018, Panacea had empowered clinicians in the early detection of breast cancer.
In 2018, Bhabhatron II was installed in Uganda and Madagascar, ensuring timely treatment of cancer in these unreached areas. With Lilac getting CE marked in 2018, Panacea had empowered clinicians in the early detection of breast cancer.